Interrupting Self-Harm Study

Sponsor
University of Utah (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03550521
Collaborator
(none)
0
1
2
12
0

Study Details

Study Description

Brief Summary

My study will employ a convergent mixed methods two-arm parallel randomized controlled design. The qualitative strand will primarily rely on semi-structured interview procedures to answer the following questions: (1) How do adolescents perceive and experience the phenomenon of nonsuicidal self-injury (NSSI)? (2) What do adolescents believe needs to be done to address NSSI? The quantitative strand will primarily rely on clinical interview data, self-report measures, and an experimental task protocol to answer the following question: What is the impact of a brief mindfulness induction (versus a control condition) on self-injury attentional bias among self-injuring adolescents?

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindfulness
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
A Mixed Methods Investigation of Brief Mindfulness Training and Self-injury Attentional Bias Among Self-injuring Adolescents
Actual Study Start Date :
Jun 1, 2018
Actual Primary Completion Date :
Jun 1, 2019
Actual Study Completion Date :
Jun 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mindfulness condition

The brief mindfulness induction will be modeled after basic mindfulness skills commonly used in mindfulness-based interventions and tailored to target distressing thoughts and feelings.

Behavioral: Mindfulness
Participants will be instructed to focus on the sensations of breathing. Subsequently, whenever their minds wander to distressing thoughts or emotions, they will be instructed to acknowledge those thoughts or emotions, and then bring their attention back to the sensations of breathing.

No Intervention: Control condition

Participants assigned to the control task will be instructed to "let your mind wander freely without trying to focus on anything in particular."

Outcome Measures

Primary Outcome Measures

  1. Change in self-injury attentional bias as measured by a Dot Probe Paradigm [The Dot Probe Paradigm will be administered immediately preceding the mindfulness or control conditions and immediately following the mindfulness or control conditions]

    Attentional bias (AB) refers to the allocation of attentional resources to specific aspects of environmental stimuli

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • To be included in the study, a participant must be: 1) at least 12 years old and no more than 18 years old, 2) able to understand and communicate in English, 3) willing and able to participate in all study procedures, and 4) currently engaging in nonsuicidal self-injury OR have a history of nonsuicidal self-injury.
Exclusion Criteria:
  • Individuals will be excluded from the study if they are experiencing a suicidal crisis at the time of the study procedures (e.g., they endorse suicidal ideation, planning, and intent as determined by the Mini International Neuropsychiatric Interview 7.0) and require crisis intervention or hospitalization.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Utah Salt Lake City Utah United States 84112

Sponsors and Collaborators

  • University of Utah

Investigators

  • Principal Investigator: Michael R Riquino, MSW, University of Utah College of Social Work

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Utah
ClinicalTrials.gov Identifier:
NCT03550521
Other Study ID Numbers:
  • IRB_00108383
First Posted:
Jun 8, 2018
Last Update Posted:
Apr 28, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 28, 2021